• State of Digital Clinical Trials Podcast

  • By: Richard Young
  • Podcast

State of Digital Clinical Trials Podcast

By: Richard Young
  • Summary

  • State of Digital Clinical Trials is a Veeva podcast hosted by Richard Young, Vice President of Strategy for Vault Clinical Data Management Suite at Veeva. Over the next few months, Richard will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric?
    Richard Young
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Is a Heavy Tech Burden the Price of Progress for Sites?
    Oct 31 2024

    Richard Young passes the torch to Manny Vazquez, our new podcast host, and shares his reflections before turning off his mic for the final time. Later, Manny is joined by renowned industry thinker and site leader Brad Hightower, owner of clinical research center Hightower Clinical in Oklahoma.


    They discuss whether the growing tech burden is the price of progress for sites, plus tips on how sponsors can make sites’ lives easier. Brad also explains a few implications of the recent FDA draft guidance on DCTs and the upcoming site conference he helped to set up, ‘Save Our Sites’.


    Show More Show Less
    53 mins
  • AI and Clinical Transformation: High-Value or Hype?
    Oct 11 2024

    Novo Nordisk’s Vice President for Clinical Data Operations and Insights Ibrahim Kamstrup-Akkaoui joins Richard this week for episode 4 of Season 3. As Ibrahim explains, the pace of innovation in clinical development is accelerating, sometimes generating billions of relevant data points for study teams to manage.


    AI is already adding value and can help organizations sustainably manage this growth. They discuss how to start small and think big with AI and concrete examples of where it is delivering for Novo Nordisk, such as generating meaningful test data and study builds.


    This discussion reflects the views and opinions of Ibrahim Kamstrup-Akkaoui in a personal capacity and does not represent those of Novo Nordisk.


    Show More Show Less
    29 mins
  • Does Data Science Require Data Perfection?
    Oct 9 2024

    Pfizer’s Vice President for Data Monitoring and Management Demetris Zambas joins Richard in the hot seat and shares his fascinating journey through life sciences: from how his childhood experiences of receiving vaccines shaped his values to his contributions to our industry’s leading companies, and everything in between.


    They discuss the evolution of data science, the potential applications of AI, and whether we still need to strive for data perfection. Although the tools have changed, the mission and successful traits of a strong data scientist remain consistent — and could soon be enhanced by an AI assistant.


    This discussion reflects the views and opinions of Demetris Zambas in a personal capacity and does not represent those of Pfizer.


    Show More Show Less
    37 mins

What listeners say about State of Digital Clinical Trials Podcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.